Sawgrass Asset Management LLC reduced its stake in shares of Clorox Co (NYSE:CLX) by 1.1% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 136,948 shares of the company’s stock after selling 1,587 shares during the quarter. Sawgrass Asset Management LLC owned about 0.11% of Clorox worth $20,968,000 at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. Mn Services Vermogensbeheer B.V. raised its stake in Clorox by 0.6% during the 1st quarter. Mn Services Vermogensbeheer B.V. now owns 70,968 shares of the company’s stock worth $11,388,000 after acquiring an additional 400 shares in the last quarter. Deutsche Bank AG raised its stake in Clorox by 10.2% during the 4th quarter. Deutsche Bank AG now owns 307,703 shares of the company’s stock worth $47,425,000 after acquiring an additional 28,361 shares in the last quarter. SlateStone Wealth LLC raised its stake in Clorox by 13.6% during the 1st quarter. SlateStone Wealth LLC now owns 5,043 shares of the company’s stock worth $809,000 after acquiring an additional 605 shares in the last quarter. Montecito Bank & Trust raised its stake in Clorox by 24.0% during the 1st quarter. Montecito Bank & Trust now owns 5,212 shares of the company’s stock worth $836,000 after acquiring an additional 1,009 shares in the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC raised its stake in Clorox by 1.1% during the 1st quarter. Kayne Anderson Rudnick Investment Management LLC now owns 35,017 shares of the company’s stock worth $5,619,000 after acquiring an additional 384 shares in the last quarter. Hedge funds and other institutional investors own 76.92% of the company’s stock.
Several brokerages recently commented on CLX. BMO Capital Markets set a $168.00 price target on shares of Clorox and gave the stock a “buy” rating in a research note on Thursday, May 2nd. ValuEngine lowered shares of Clorox from a “buy” rating to a “hold” rating in a research note on Thursday. UBS Group raised their price objective on shares of Clorox from $110.00 to $128.00 and gave the stock a “sell” rating in a research report on Friday. Zacks Investment Research raised shares of Clorox from a “sell” rating to a “hold” rating and set a $175.00 price objective on the stock in a research report on Monday. Finally, Royal Bank of Canada raised their price objective on shares of Clorox to $161.00 and gave the stock a “sector perform” rating in a research report on Friday. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and two have assigned a buy rating to the company. Clorox currently has a consensus rating of “Hold” and an average target price of $153.93.
Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, August 1st. The company reported $1.88 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.84 by $0.04. The company had revenue of $1.63 billion for the quarter, compared to the consensus estimate of $1.69 billion. Clorox had a net margin of 12.68% and a return on equity of 108.82%. Clorox’s revenue for the quarter was down 3.8% on a year-over-year basis. During the same period last year, the firm posted $1.66 EPS. Research analysts anticipate that Clorox Co will post 6.29 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, August 16th. Stockholders of record on Wednesday, July 31st will be issued a $1.06 dividend. This is an increase from Clorox’s previous quarterly dividend of $0.96. The ex-dividend date is Tuesday, July 30th. This represents a $4.24 annualized dividend and a dividend yield of 2.69%. Clorox’s payout ratio is presently 67.73%.
In other news, SVP Denise Garner sold 20,399 shares of Clorox stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $157.61, for a total value of $3,215,086.39. Following the sale, the senior vice president now owns 4,896 shares of the company’s stock, valued at $771,658.56. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.40% of the stock is owned by insiders.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Story: What can cause a stock to outperform?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.